TY - JOUR
T1 - Biventricular pacing in congestive heart failure
T2 - A boost toward finer living
AU - Luck, Jerry C.
AU - Wolbrette, Deborah L.
AU - Boehmer, John P.
AU - Ulsh, Paula J.
AU - Silber, David
AU - Naccareli, Gerald V.
PY - 2002
Y1 - 2002
N2 - With 550,000 new cases each year, congestive heart failure is a major medical problem. Several medical therapies, including digoxin, angiotensin-converting enzyme inhibitors, and beta-blockers, have reduced the number of re-hospitalizations and slowed the progression of congestive heart failure. Angiotensin-converting enzyme inhibitors, some beta-blockers, and the combination of hydralazine with nitrates have improved survival. Despite these benefits, medical therapy frequently fails to improve quality of life. Biventricular pacing has been introduced to resynchronize mechanical and electrical asynchrony frequently observed in patients with heart failure. The most recent pacing trials show an improvement in quality of life and functional class. Long-term data are needed to determine the effect of biventricular pacing on survival. The acute hemodynamic studies suggest that resynchronization pacing therapy may predict a positive long-term benefit for many patients with congestive heart failure.
AB - With 550,000 new cases each year, congestive heart failure is a major medical problem. Several medical therapies, including digoxin, angiotensin-converting enzyme inhibitors, and beta-blockers, have reduced the number of re-hospitalizations and slowed the progression of congestive heart failure. Angiotensin-converting enzyme inhibitors, some beta-blockers, and the combination of hydralazine with nitrates have improved survival. Despite these benefits, medical therapy frequently fails to improve quality of life. Biventricular pacing has been introduced to resynchronize mechanical and electrical asynchrony frequently observed in patients with heart failure. The most recent pacing trials show an improvement in quality of life and functional class. Long-term data are needed to determine the effect of biventricular pacing on survival. The acute hemodynamic studies suggest that resynchronization pacing therapy may predict a positive long-term benefit for many patients with congestive heart failure.
UR - http://www.scopus.com/inward/record.url?scp=0036147356&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036147356&partnerID=8YFLogxK
U2 - 10.1097/00001573-200201000-00014
DO - 10.1097/00001573-200201000-00014
M3 - Review article
C2 - 11790940
AN - SCOPUS:0036147356
SN - 0268-4705
VL - 17
SP - 96
EP - 101
JO - Current Opinion in Cardiology
JF - Current Opinion in Cardiology
IS - 1
ER -